B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 2.14 EUR 7% Market Closed
Market Cap: 49.9m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Bioretec Oy
Investor Relations

Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.

Show more

Earnings Calls

No Earnings Calls Available

Management

Timo Lehtonen
Chief Exec. Officer
No Bio Available
Johanna Salko
Chief Financial Officer
No Bio Available
Mr. Esa Hallinen
Director of Operations
No Bio Available
Kimmo Lahteenkorva
Chief Technology Officer
No Bio Available
Mr. Rami Ojala
Sales & Marketing Director
No Bio Available

Contacts

Address
LANSI-SUOMEN
Tampere
Yrittajankulma 5
Contacts
+358207789500
bioretec.com